World Menopause Day

Experiencing menopause before the age of 45 is associated with a higher risk of bladder cancer particularly among smokers Picture: File

Experiencing menopause before the age of 45 is associated with a higher risk of bladder cancer particularly among smokers Picture: File

Published Oct 19, 2024

Share

Among many women, there is still uncertainty about Menopause Hormone Therapy (MHT), resulting in confusion and missed opportunities for effective treatment. This year’s World Menopause Day (October 18) aims to equip women with accurate information to help them make empowered health choices during menopause.

According to Dr Trudy Smith, a Johannesburg-based Obstetrician and Gynaecologist, “Menopause is a natural transition, but it often brings symptoms that disrupt daily life. It is therefore critical that women are empowered to seek support and have access to the treatment they require”.

Understanding menopause and MHT Menopause marks the absence of menstrual periods for 12 consecutive months. Symptoms such as hot flushes, night sweats, and mood changes often start during perimenopause and can continue long after menopause. These symptoms can have a profound impact on a woman’s well-being.

MHT is the most effective way to control menopausal symptoms while also providing other health benefits. Oestrogen, the primary hormone used in MHT, helps alleviate hot flushes, night sweats, and vaginal dryness.

For women with a uterus, progesterone must be included in an MHT regimen to protect the lining of the womb from excessive growth caused by oestrogen.

“MHT remains the most effective option for managing hot flushes and night sweats.

It can also reduce long-term health risks like osteoporosis and heart disease. However, a personalised approach is essential, with professional guidance to

evaluate the potential risks and benefits,” explained Dr Smith. .

The safety of MHT has been well debated, especially around breast cancer and

cardiovascular risks. The International Menopause Society’s latest White Paper clarifies that for most healthy women starting MHT within ten years of menopause, the benefits outweigh the risks. Women with certain health histories - such as breast cancer or clotting conditions - may need to explore non-hormonal alternatives.

Dr Smith emphasised that it is crucial that each woman discusses her individual circumstances with her healthcare provider to determine the best course of action. The spread of misinformation has led many women to avoid evidence-based treatments or opt for unproven remedies.

“The South African Menopause Society’s goal is to ensure that every woman feels empowered to make informed decisions about her health and receives

the support she needs to navigate this life stage with confidence and comfort,” concluded Dr Smith.

The South African Menopause Society (SAMS) is a medical association of healthcare professionals dedicated to promoting women’s health during midlife and beyond, through the understanding of menopause.

SAMS membership comprises leaders in the field of health care including clinical and basic science experts from medicine, nursing, physiotherapy, psychology, nutrition, anthropology, epidemiology, and education. This multi-disciplinary focus sets SAMS as a dominant resource on all aspects of menopause to both healthcare providers and the public.